Nuveen Asset Management, LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$83,669
-98.0%
65,881
-94.7%
0.00%
-100.0%
Q2 2023$4,084,835
+79963.4%
1,241,591
+0.0%
0.00%
-50.0%
Q1 2023$5,102
-29.2%
1,241,487
+1.0%
0.00%
-33.3%
Q4 2022$7,204
-99.9%
1,229,407
-3.1%
0.00%0.0%
Q3 2022$8,579,000
+320.3%
1,269,121
+187.2%
0.00%
+200.0%
Q2 2022$2,041,000
+70.4%
441,834
+47.5%
0.00%
Q1 2022$1,198,000
-34.2%
299,450
+2.2%
0.00%
-100.0%
Q4 2021$1,822,000
-30.0%
292,957
+6.1%
0.00%0.0%
Q3 2021$2,604,000
-26.3%
276,188
+6.2%
0.00%0.0%
Q2 2021$3,531,000
-10.0%
259,948
+7.2%
0.00%0.0%
Q1 2021$3,922,000
-62.8%
242,429
-38.8%
0.00%
-75.0%
Q4 2020$10,538,000
+53.3%
396,043
+7.3%
0.00%
+33.3%
Q3 2020$6,874,000
-41.6%
369,186
-26.6%
0.00%
-40.0%
Q2 2020$11,769,000
+944.3%
502,951
+160.2%
0.01%
+400.0%
Q1 2020$1,127,000
+41.4%
193,283
+39.0%
0.00%
Q4 2019$797,000
+366.1%
139,081
+29.0%
0.00%
Q3 2019$171,000
-60.9%
107,8090.0%0.00%
Q2 2019$437,000107,8090.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders